KEY FEATURES
| Full Name | Urokinase-Type Plasminogen Activator |
|---|---|
| Synonym | UPA, u-PA, ATF, URK, UP-A, Urokinase, Abbokinase |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 15.6-1000pg/mL |
| Sensitivity | 6pg/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human PLAU/uPA in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human PLAU/uPA. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human PLAU/uPA and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human PLAU/uPA, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human PLAU/uPA. You can calculate the concentration of Human PLAU/uPA in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human PLAU/uPA ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (pg/mL) | 54.78 | 150.53 | 447.39 | 52.59 | 159.86 | 407.63 |
| Standard deviation | 3.65 | 7.23 | 19.73 | 2.9 | 9.21 | 13.41 |
| CV(%) | 6.67 | 4.8 | 4.41 | 5.52 | 5.76 | 3.29 |
RECOVERY
The recovery of Human PLAU/uPA spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 95-108 | 101 |
| EDTA plasma (n=8) | 89-100 | 95 |
| Cell culture media (n=8) | 87-103 | 94 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human PLAU/uPA in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with uPA ELISA Kits
| PLAUR ELISA Kit | publications with uPA and PLAUR |
| MMP9 ELISA Kit | publications with uPA and MMP9 |
| SERPINE1 ELISA Kit | publications with uPA and SERPINE1 |
| SERPINB2 ELISA Kit | publications with uPA and SERPINB2 |
| FN1 ELISA Kit | publications with uPA and FN1 |
| EGFR ELISA Kit | publications with uPA and EGFR |
| PLG ELISA Kit | publications with uPA and PLG |
| VLDLR ELISA Kit | publications with uPA and VLDLR |
Pathways associated with uPA ELISA Kit
| ATF-2 Transcription Factor Network Pathway | ATF-2 Transcription Factor Network Pathway |
| Blood Clotting Cascade Pathway | Blood Clotting Cascade Pathway |
| Complement And Coagulation Cascades Pathway | Complement And Coagulation Cascades Pathway |
| DNA Damage Response (only ATM Dependent) Pathway | DNA Damage Response (only ATM Dependent) Pathway |
| Dissolution Of Fibrin Clot Pathway | Dissolution Of Fibrin Clot Pathway |
| E2F Transcription Factor Network Pathway | E2F Transcription Factor Network Pathway |
| Endochondral Ossification Pathway | Endochondral Ossification Pathway |
| FGF Signaling Pathway | FGF Signaling Pathway |
Diseases associated with uPA ELISA Kit
| Adenocarcinoma | publications with uPA and Adenocarcinoma |
| Inflammation | publications with uPA and Inflammation |
| Alzheimer Disease | publications with uPA and Alzheimer Disease |
| Neoplasm Invasiveness | publications with uPA and Neoplasm Invasiveness |
| Prostatic Neoplasms | publications with uPA and Prostatic Neoplasms |
| Neoplasm Metastasis | publications with uPA and Neoplasm Metastasis |
| Stomach Neoplasms | publications with uPA and Stomach Neoplasms |
| Pancreatic Neoplasms | publications with uPA and Pancreatic Neoplasms |
| Hemorrhage | publications with uPA and Hemorrhage |
| Necrosis | publications with uPA and Necrosis |
Organs/Tissues associated with uPA ELISA Kit
| Blood | publications with uPA and Blood |
| Lung | publications with uPA and Lung |
| Brain | publications with uPA and Brain |
| Bone | publications with uPA and Bone |
| Prostate | publications with uPA and Prostate |
| Vascular | publications with uPA and Vascular |
| Liver | publications with uPA and Liver |
| Stomach | publications with uPA and Stomach |
| Skin | publications with uPA and Skin |
| Placenta | publications with uPA and Placenta |